Skip to content
  • Tuesday, 17 November 2026
  • 8:58 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Amberstone, Henlius agree to develop solid-tumour T-cell engagers
Pharmaceutical R&D

Amberstone, Henlius agree to develop solid-tumour T-cell engagers

Teuku Ryan Sep 27, 2026 0

Biotechnology innovation continues to push the boundaries of oncology as companies seek safer and more effective ways to harness the…

Read More
The Hypothalamus Connection: How a Single Brain Protein May Hold the Key to Systemic AgingThe Invisible Conflict Two-Component Dark Matter Model Explains Discrepancy Between Milky Way Gamma-Ray Excess and Dwarf Galaxy ObservationsIndiana University Scientists Develop Breakthrough Multiplex Imaging Technique to Map Bone Marrow MicroenvironmentsExpert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring SystemThe oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
YOU MAY HAVE MISSED
Neuroscience & Brain Research
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring System
Rifan Muazin Nov 5, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ